Heidelberger Druckmaschinen AG

Q1 order intake was EUR 537 million, down 4% from EUR 560 million a year ago. Net sales were EUR 404 million, down 13% from EUR 466 million. Adjusted EBITDA was EUR 1 million versus EUR 20 million last year, and adjusted EBITDA margin was 0.2% versus 4.4%, a decline of 420 basis points. Free cash flow was negative EUR 77 million versus negative EUR 68 million. Headcount fell to 9,019 from 9,228, staff costs declined to EUR 196 million from EUR 208 million, and the backlog increased to EUR 762 million from EUR 639 million. For full-year 2026-2027, Heidelberg expects net sales to remain broadly stable versus the prior year and adjusted EBITDA margin to improve noticeably; the outlook excludes currency effects and assumes macro/industry conditions stay broadly as expected.

Jurgen Otto framed the quarter as evidence that Heidelberg is progressing on a broader strategic reset, even in a difficult market. He highlighted the company’s push into security and defense, energy storage, digital partnerships, and low-cost production, saying these initiatives are meant to reduce reliance on traditional printing and improve long-term resilience. His tone was constructive and confident, emphasizing that the strategy is creating synergies and future growth options.

Volker Herdin said the weak Q1 was expected seasonally and was mainly driven by lower volume, especially after the Italian incentive program ended. He cited the backlog increase to EUR 762 million, the adjusted EBITDA margin of 0.2%, and the contribution margin ratio improving to 32.6%, up 110 basis points year over year. He also pointed to cash discipline, noting operating cash flow of negative EUR 55 million, free cash flow of negative EUR 77 million, net working capital of negative EUR 12 million, and undrawn revolving credit facility capacity of EUR 298 million out of EUR 436 million. Capital allocation remains focused first on investing in new businesses such as defense and energy, then strengthening the core, with shareholder distributions ranked third.

Analysts pressed management on how the company can still deliver full-year margin improvement after a weak Q1, especially with acquisitions and defense investments. Management said the main lever is a sales rebound combined with cost savings, and confirmed that group margin should expand in Q2 year over year. Questions on cash flow and dividends drew a clear answer: free cash flow should be less negative as the year progresses, but still negative for the full year, and capital allocation will prioritize growth investments over dividends or buybacks. On Phenogy, management said the goal is a Europe-made turnkey stationary energy storage system, with Heidelberg contributing industrialization and integration capabilities, while Phenogy brings chemistry and market expertise.